Washington, Apr 30 : A new pill may soon replace the painful injections for multiple sclerosis treatment, say researchers.
The research team led by Professor Gavin Giovannoni of Barts and The London School of Medicine and Dentistry has shown that cladribine tablets just a few times a year can reduce the chances of a relapse by well over 50 per cent.
Cladribine tablets work by suppressing the immune system, reducing the risk of further damage to a patient''s nervous system.
In the new study, the researchers followed over 1,300 MS patients for nearly two years.